Jiangsu Wuzhong Hot money Rob raise three degrees continuous trading

Wuzhong, Jiangsu (600200) Trading yesterday, closed to 11.22 yuan, in less than two months, the share price nearly doubled, and refreshed record highs.　　Combined with information on public transactions, the reporter found that, since last November, Jiangsu Wuzhong has repeatedly been held by the hot money, this time strength again, mainly by the force of "radiation-resistant" concept hold sedan chair. Continuous "headhunt", less than six months in Jiangsu Wuzhong has been staged three times. The first was November 26 last year, when the rise was driven by announcements from the company on 26th. According to the bulletin, the company is currently studying the "National class of biological anticancer drugs recombinant human vascular endothelial endostatin injection of research and development and industrialization" project, access to scientific and technological achievements in the transformation of 10 million yuan special funding support, but also to obtain ancillary project funding of 2 million yuan, and the project Department for the three phase of clinical The infusion of funds to the market optimistic about a class of biological anticancer drugs for practical reasons. Thereafter, to November 30 consecutive three days trading. The second is March 1 this year, the company again announced, its 3 authorized patents, the application of global Patent 1 "recombinant human vascular endothelial inhibitor injection" has been SFDA drug clinical trial approval, the product Phase III clinical work will be fully launched, and has a clear timetable, is expected to complete 2 years or so three clinical research. This led to the "brace", again rose three consecutive days.　　If the stock price again trading today, together with the day before and yesterday's performance, will continue to write the third "Headhunt" brilliant, the stock's phased strong starkly expose anti-liberal. In response to the recent strong limit of Jiangsu Wuzhong, Warfarin Securities pharmaceutical industry researcher Sin Haibo analysis, although the new product prospects are bright and does constitute a real positive, but at present can not give a specific assessment of the company's performance.　　Yesterday's trading more affected by the Japanese earthquake after the "radiation-resistant" concept of stimulation. Indeed, the radiation impact of the explosion of nuclear power units after the Japanese earthquake caused widespread concern.　　Monday, the medical unit responded to a strong, to 3.04% of the rise in the plate first, at the same time the amount of capital inflow, which anti-cancer plate is lead, Hai Xin shares, Fengyuan Pharmaceutical, orchid Health shares have soared. Public trading information shows that the Jiangsu Wuzhong three times the rally is the active money in the positive long, and buying surges. March 1 before the five brokerage department of the purchase and sale of the amount of difference, the first 5 buy the total amount of seats amounted to 59.9 million yuan, and the first 5 sold the total amount of seats only 7.36 million yuan, buy a plate is sold more than 8 times times more. March 11, the public trading information showed that the purchase of the stock, the first 5 buy seats amounted to 163 million yuan, the first 5 sold seats total amount of only 50.44 million, buy a plate is sold more than 3 times times more. In addition, the reporter also found that in the March 1 and March 11 of the two waves of rising, the Hunan Treasury securities Hangzhou Teachers Road Sales department are among the top five, Guotai Shenzhen Yitian Sales Department and the state Letter of the securities of Shenzhen Nine road sales department also unwilling to do, frequent appearance. Yesterday, the latest is the Everbright Securities Shenzhen Shennan Middle Road Sales department, Treasury securities wenling Donghui North Road CampThe Ministry of Industry and other more established capital camp. In general, the buying period of Jiangsu Wuzhong is active for a long period, the stock price trend and the progress of anticancer New drug bulletin basically coincide, but recently borrowed force "anti-radiation" concept so easy to limit, it is the homeopathy of the floating capital. In this respect, Sin Haibo explained that "radiation-resistant" is only a short-term factor in the strength of the medical unit, also can not do a qualitative analysis, its hype probability is greater. He advises investors to invest more in the development of industry and corporate fundamentals. Responsible Editor: NF058